Wearable Healthcare Devices Market Report 2026

The wearable healthcare devices market size has grown rapidly in recent years. It will grow from $30.75 billion in 2025 to $34.41 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing consumer awareness of personal health and fitness tracking, rapid adoption of smartphones enabling wearable connectivity, growing prevalence of lifestyle-related diseases, expansion of digital health and telemedicine platforms, declining cost of sensor and wearable technology components.

The wearable healthcare devices market size is expected to see rapid growth in the next few years. It will grow to $54.44 billion by 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to rising integration of ai-based personalized health insights in wearables, increasing adoption of remote patient monitoring in healthcare systems, expansion of interoperable cloud health data platforms, growing demand for continuous non-invasive health monitoring devices, advancement in miniaturized biosensors and energy-efficient wearable technologies. Major trends in the forecast period include rising integration of ai-powered predictive health analytics in wearable devices, increasing adoption of continuous remote patient monitoring through connected wearables, expansion of cloud-based health data ecosystems for real-time health tracking, growing use of wearable devices for preventive healthcare and early disease detection, rising demand for multi-parameter biosensor wearables for personalized health insights.

The increasing prevalence of chronic diseases is expected to propel the growth of the wearable healthcare devices market going forward. Chronic diseases are long-term medical conditions that develop gradually and require continuous management, including cardiovascular diseases, diabetes, cancer, and chronic respiratory disorders, and they are affecting an increasing proportion of the global population across both developed and developing regions. The prevalence of chronic diseases is mainly driven by sedentary lifestyles and unhealthy dietary habits, which contribute to long-term metabolic and cardiovascular complications. Wearable healthcare devices support this trend by allowing continuous physiological monitoring, enabling early detection of abnormalities, and enhancing patient adherence to treatment through real-time health insights. For instance, in December 2023, according to UnitedHealth Group, a U. S. -based health organization, the prevalence of eight major chronic conditions reached record levels in 2023, while diabetes affected approximately 11.5% of adults (around 31.9 million people). Therefore, the increasing prevalence of chronic diseases is driving the growth of the wearable healthcare devices market.

Leading companies operating in the wearable healthcare devices market are focusing on the integration of advanced multi-metric sensor technologies to improve health insights and support preventive care. Advanced multi-metric sensors refer to integrated sensing technologies capable of monitoring multiple physiological parameters simultaneously, including heart rate variability, body temperature fluctuations, respiratory rate, and activity levels, enabling comprehensive real-time health monitoring. For instance, in August 2023, Withings, a France-based digital health company, launched its next-generation ScanWatch 2 and ScanWatch Light. These devices feature upgraded sensors that enable continuous 24/7 monitoring of additional health metrics beyond standard tracking, including baseline body temperature variation, heart-rate variability, respiratory rate, and female cycle tracking. The devices also integrate advanced MultiWave PPG sensors and high dynamic range accelerometers to automatically detect more than 40 activities, delivering deeper health insights and improving personalized health management.

In September 2023, Abbott Laboratories, a US-based healthcare technology company, acquired Bigfoot Biomedical for an undisclosed amount. Through this acquisition, Abbott aimed to reinforce its diabetes care portfolio by strengthening digital health capabilities and expanding its presence in connected wearable insulin management solutions, improving patient outcomes and enabling more efficient remote monitoring. Bigfoot Biomedical is a US-based healthcare technology company specializing in wearable-integrated diabetes management devices.

Major companies operating in the wearable healthcare devices market are Apple Inc., Samsung Electronics Company Limited, Huawei Technologies Company Limited, Abbott Laboratories Inc., Medtronic PLC, Senseonics Holdings Incorporated, Koninklijke Philips Naamloze Vennootschap, GE HealthCare Technologies Inc., Garmin Limited, Omron Corporation, Dexcom Incorporated, Insulet Corporation, Sotera Wireless Incorporated, Tandem Diabetes Care Incorporated, Ypsomed Holding Aktiengesellschaft, Withings Société par Actions Simplifiée, Owlet Incorporated, AliveCor Incorporated, Qardio Incorporated, ForaCare Suisse AG, Corsano Health Besloten Vennootschap, Movano Health Incorporated, NeuroMetrix Incorporated, Shenzhen Viatom Technology Company Limited.

North America was the largest region in the wearable healthcare devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wearable healthcare devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the wearable healthcare devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The wearable healthcare devices market consists of smartwatches, fitness bands, smart rings, wearable electrocardiogram monitors, wearable blood pressure monitors, and wearable glucose monitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.